Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LiveSMART: Sequential Lactulose and TeleTai-Chi to Prevent Falls in Cirrhosis
NCT05794555Phase 3Completed
- Sponsor
- University of Michigan
- Start
- Jun 2023
- Primary completion
- Mar 2025
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of lactulose in Cirrhosis, Portal Hypertension (PH), sponsored by University of Michigan. Started Jun 2023; status: completed.
02
Drugs
lactulose
03
Conditions
CirrhosisPortal Hypertension (PH)
Beyond the preview
Go deeper on NCT05794555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05794555.